Glaxo Group Limited

United Kingdom


 
Total IP 4,522
Total IP Rank # 231
IP Activity Score 4/5.0    2,451
IP Activity Rank # 275
Parent Entity GlaxoSmithKline plc
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

165 944
26 1,034
882 1,188
283
 
Last Patent 2024 - Combinations of a muscarinic rec...
First Patent 1978 - Device for dispensing medicaments
Last Trademark 2024 - O ORZELIA
First Trademark 1958 - MAREVAN

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases;...
G/S (Based on Intent to Use) Vaccines; Anti-infectives; Pharmaceutical preparations for the preventio...
G/S Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infections diseases;...
G/S Antibiotic preparations
G/S Pharmaceutical preparations for the prevention, treatment and/or alleviation of migraine and othe...
G/S Pharmaceutical and medicinal preparations and substances; vaccines.
G/S Downloadable publications relating to respiratory diseases and disorders Printed publications inc...
2023 G/S Pharmaceutical and medicinal preparations and substances; vaccines.
G/S Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damage...
G/S (Based on 44(d) Priority Application) Vaccines; Anti-infectives; Pharmaceutical preparations and ...
G/S Downloadable publications relating to respiratory diseases and disorders. Printed publications in...
Invention Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist. Combinatio...
2022 Invention Dry powder inhalation drug products exhibiting moisture control properties and methods of adminis...
Invention Antigen binding proteins. The present invention concerns antigen binding proteins and fragments ...
2021 Invention Modulation of hepatitis b virus (hbv) expression. Disclosed herein are antisense compounds and m...
2020 Invention Modified proteins and peptides. The present invention relates to modified proteins and peptides ...
Invention Antigen binding proteins to oncostatin m (osm). The present invention concerns antigen binding p...
Invention Anti-serum albumin binding variants. The invention relates to improved variants of the anti-seru...
Invention Compounds. The invention is directed to compounds of formula (I): and salts thereof. The compou...
Invention Antigen binding proteins. The present invention concerns antigen binding proteins and fragments t...
Invention Compositions and methods for modulating hbv expression. Provided herein are oligomeric compounds...
2019 Invention Medicament dispenser. An inhalation device having at least one elongate medicament carrier inclu...
2018 Invention Label set for an inhalation device
Invention Method of treatment with humanized anti-il-18 antibodies. The present invention discloses humanis...
2017 Invention Ligands that bind tgf-beta receptor ii. The disclosure provides an anti-TGFbetaRII immunoglobuli...
Invention 2-(azaindol-2-yl) benzimidazoles as pad4 inhibitors. 1-6alkyl; and salts thereof are PAD4 inhibit...
Invention Compositions and methods for modulating ttr expression. Provided herein are oligomeric compounds ...
Invention Methods for selecting protease resistant polypeptides. The disclosure relates to a method for sel...
Invention Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist. Combination...
Invention Positive allosteric modulators of human melanocortin-4 receptor. Disclosed herein are positive al...
Invention Process for separation of oligonucleotide of interest from a mixture. A method for separation of...
Invention 2 substituted cephem compounds. The compounds of the subject invention are related to 2-substitut...
Invention Novel compounds. The invention is directed to methods of treatment using compounds of formula (I...
Invention Antigen binding proteins to oncostatin m (osm). The present invention concerns antigen binding pr...
Invention Anti-serum albumin binding variants. The invention relates to improved variants of the anti-serum...
2016 Invention Novel compounds. The present invention is directed to novel retinoid-related orphan receptor gam...
Invention 2-(azaindol-2-yl) benzimidazoles as pad4 inhibitors. Compounds of formula (I): and salts thereo...
Invention Immunoglobulins. The present invention discloses humanised anti-IL-18 antibodies, methods of man...
Invention Antigen binding constructs. The present invention is directed to antigen binding constructs comp...
Invention Inhaler device
Invention Crystal form. A novel crystalline form of a compound is disclosed.
Invention Novel compounds. A compound of formula (I): A compound of formula (I): or a salt there...
Invention Novel compounds. The invention is directed to certain novel compounds. Specifically, crystalline...
Invention Treatment for vitiligo. A method of treating vitiligo, including prophylaxis, in a subject in ne...
Invention Treatment for vitiligo. A method of treating vitiligo, including prophylaxis, in a subject in nee...
Invention Method of producing a recombinant protein. The present invention relates to a method of producing...
2015 Invention Child-proof package. A package which can be torn open by a user, comprising a polymer film mater...
2014 Invention Novel milk beverage composition comprising creatine. Ready to drink milk beverage compositions a...